CGM Study Shows Sex Is Safe for Type 1 Diabetes
A small study using continuous glucose monitors suggests sexual activity does not pose a safety risk for people with type 1 diabetes.
New research scheduled for presentation at the European Association for the Study of Diabetes annual meeting in Milan indicates that sexual activity is safe for adults with type 1 diabetes. The study relied on continuous glucose monitoring devices to track glucose levels during intercourse, providing a real-world look at a topic that is often overlooked in diabetes care.
According to the researchers, the findings offer reassurance to patients and clinicians. While the study was small, its use of CGM data gives a detailed picture of glucose behaviour during sexual activity, and the results suggest that concerns about dangerous highs or lows may be unfounded.
Because the work has not yet been peer-reviewed and is being presented at a conference, these conclusions should be considered preliminary. Still, the study highlights the value of CGM in exploring everyday situations that can affect diabetes management.
More in Medicine & Biotech
Ebola Vaccine Trial Launches in DR Congo Outbreak Zone
Health workers in DR Congo have begun testing whether a vaccine designed for a different Ebola strain can protect against the current outbreak.
Beacon Gene Therapy for Rare Vision Loss Succeeds in Pivotal Trial
A pivotal trial of Beacon Therapeutics' gene therapy for X-linked retinitis pigmentosa improved visual acuity, clearing the path toward an FDA submission.
Alkermes orexin agonist shows early promise for ADHD
Early-stage data suggest Alkermes' orexin agonist could expand the drug class beyond sleep disorders into ADHD.
Telix to Buy ITM for $1.65B, Challenging Novartis in Radiopharma
The acquisition gives Telix a late-stage pipeline and supply network that could compete with Novartis' Lutathera.